Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...

A pregnancy-related protein, PZP, shows promise as a biomarker for poor survival and immune changes in women with lung ...

Non-coding RNAs (ncRNAs), once considered the 'dark matter' of the genome, have now emerged as pivotal regulators in cancer ...

Lung cancer can co-opt genes that normally help a fetus develop and evade the mother's immune system. And while these pregnancy-specific glycoproteins (PSGs) can get activated in the cancers of both ...

A critical imbalance in bile acids can trigger liver diseases, including cancer. Researchers have identified a key molecular ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Lung cancer can co-opt genes that normally help a fetus develop and evade the mother's immune system. And while these ...

ERAS-0015 and ERAS-4001 showed robust anti-tumor activity as monotherapy and combination therapy First-in-class examples of direct SHOC2 binders and modulators of SMP complex assembly identified with ...

Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

LX-101, a Novel, Clinical Stage, Payload-Bearing Targeted Therapy Directed to the Insulin-Like Growth Factor Receptor (IGF-1R), Demonstrates Potent Anti-Tumor Activity in Ewing Sarcoma Animal Models ...